NEVVI Medicare utilization intelligence

← back

SHERMAN, JOELM.D. NPI 1760460430 Clinician

Urology · STATEN ISLAND, NY

Specialty Urology — from billed Medicare claims
Trained STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 34 years since medical school (class of 1992, self-reported to CMS)
Location STATEN ISLAND, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 55 codes billed · 101,367 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-06

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J1071 Injection, testosterone cypionate, 1 mg premiumpremium premiumpremium
87798 Detection test by nucleic acid for organism, amplified probe technique premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
51798 Ultrasound measurement of bladder capacity after voiding premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
82570 Creatinine level to test for kidney function or muscle injury premiumpremium premiumpremium
87481 Detection test for candida species (yeast), amplified probe technique premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
88313 Special stained specimen slides to examine tissue including interpretation and report premiumpremium premiumpremium
88112 Cell examination of specimen, selective cellular enhancement technique premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
76770 Complete ultrasound scan behind abdominal cavity premiumpremium premiumpremium
88120 Cell examination of urine, manual premiumpremium premiumpremium
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique premiumpremium premiumpremium
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
76872 Ultrasound scan of pelvic region through rectum premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional premiumpremium premiumpremium
88305 Pathology examination of tissue using a microscope, intermediate complexity premiumpremium premiumpremium
97032 Application of electrical stimulation with therapist present, each 15 minutes premiumpremium premiumpremium
51741 Electronic assessment of bladder emptying premiumpremium premiumpremium
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique premiumpremium premiumpremium
87511 Detection test for gardnerella vaginalis (bacteria), amplified probe technique premiumpremium premiumpremium
51792 Assessment of muscle signal of pelvic nerves premiumpremium premiumpremium
51702 Simple insertion of temporary bladder tube premiumpremium premiumpremium
G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
87491 Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique premiumpremium premiumpremium
87563 Detection of mycoplasma genitalium by dna or rna probe premiumpremium premiumpremium
87591 Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique premiumpremium premiumpremium
87661 Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique premiumpremium premiumpremium
87496 Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique premiumpremium premiumpremium
91122 Study of rectum sensitivity and function premiumpremium premiumpremium
52281 Dilation of urethra using an endoscope premiumpremium premiumpremium
J7050 Infusion, normal saline solution, 250 cc premiumpremium premiumpremium
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies premiumpremium premiumpremium
51797 Insertion of device into abdomen with pressure and urine flow rate study premiumpremium premiumpremium
52224 Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm premiumpremium premiumpremium
J1580 Injection, garamycin, gentamicin, up to 80 mg premiumpremium premiumpremium
52000 Diagnostic exam of bladder and urethra using an endoscope premiumpremium premiumpremium
76942 Ultrasonic guidance for needle placement premiumpremium premiumpremium
55700 Biopsy of prostate gland premiumpremium premiumpremium
97750 Test or measurement for functional capacity, each 15 minutes premiumpremium premiumpremium
51725 Simple measurement of pressure of urine flow in bladder premiumpremium premiumpremium
96374 Injection of drug or substance into vein premiumpremium premiumpremium
52214 Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
93975 Complete ultrasound of abdomen and pelvis artery and vein blood flow premiumpremium premiumpremium
93923 Complete ultrasound study of arm and leg arteries premiumpremium premiumpremium
76775 Limited ultrasound scan behind abdominal cavity premiumpremium premiumpremium
52648 Complete laser vaporization of prostate including control of bleeding using an endoscope premiumpremium premiumpremium
52317 Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.